0% found this document useful (0 votes)
94 views11 pages

Discounted Cash Flows at WACC

Download as xls, pdf, or txt
Download as xls, pdf, or txt
Download as xls, pdf, or txt
You are on page 1/ 11

Year Ended December 31, 2008

Net Sales Growth rate

Net sales $191,100,000.00


New Construction $120,010,800.00
62.80%
Repair and Conversion $71,089,200.00
37.20%
78.09% Cost of sales $149,231,000.00
21.91% Gross profit 41,869,000
Operating expenses:
0% General and administrative
Rent -
3% Selling and marketing 5,480,000
28.37% EBIT 36,389,000
36% Taxes 13,023,000
EBIT(1-T) 23,366,000
+ Depreciation 457
-3% - Capital Expenditures (6,000,000)
-7.85% - Chg WC (15,007,853)
FCFF 2,358,604

-
Discounted Cash Flows at WACC

FCFF 2,358,604
Terminal Value
Total Discounted Cash Flows 2,358,604
Enterprise Value 116,785,783
Cost of Capital 15%
Terminal Value Growth Rate 1%

Summary DCF Valuation


DCF Enterprise Value $116,785,783.2
Less: Net Debt (10,905,000)
Equity Value ###
Shares Outstanding 6,987,000
Price per Share $15.1540
2009 2010 2011 2012
-42.00% 1.00% 1.00% 1.00%

$110,838,000.00 $111,946,380.00 $113,065,843.80 $114,196,502.24


$39,748,800.00 $40,857,180.00 $41,976,643.80 $43,107,302.24
0.00% 0.00% 20.00% 0.00%
$71,089,200.00 $71,089,200.00 $71,089,200.00 $71,089,200.00

$86,553,980.00 $87,419,519.80 $88,293,715.00 $89,176,652.15


24,284,020 24,526,860 24,772,129 25,019,850

- - - -

3,178,400.00 3,210,184.00 3,242,285.84 3,274,708.70


31,444,741 31,759,188 32,076,780 32,397,548
11,253,534 11,366,070 11,479,730 11,594,528
20,191,206 20,393,118 20,597,050 20,803,020
265 268 270 273
(3,480,000) (3,514,800) (3,549,948) (3,585,447)
(6,303,298) 87,046 87,916 88,795
10,408,173 16,965,632 17,135,288 17,306,641

Year
1 2 3 4

10,408,173 16,965,632 17,135,288 17,306,641

9,050,585 12,828,455 11,266,730 9,895,128


2013 Terminal Year
1.00% 1.00%

$115,338,467.26
$44,249,267.26
0.00%
$71,089,200.00

$90,068,418.67
25,270,049

3,307,455.79
32,721,523
11,710,473
21,011,050
276
(3,621,302)
89,683
17,479,707 17,654,504

5 TV

10%
17,479,707 126,103,603 -50% -0.38
126,103,603 -40% 0.05
71,386,281 -30% 0.47
-20% 0.9
Sales 2010 Increase
-10% 1.32
0% 1.75
5% 1.96
10% 2.17
EBIT Margins
12% 14% 16% 18% 20%
0.43 1.24 2.05 2.86 3.67
0.99 1.92 2.86 3.79 4.73
1.54 2.6 3.66 4.72 5.79
2.09 3.28 4.47 5.66 6.84
2.64 3.95 5.27 6.59 7.9
3.19 4.63 6.07 7.52 8.96
3.46 4.97 6.48 7.98 9.49
3.74 5.31 6.88 8.45 10.02

average $6.12
22% 24% 26%
4.48 5.29 6.1
5.67 6.6 7.54
6.85 7.91 8.98
8.03 9.22 10.41
9.22 10.53 11.85
10.4 11.84 13.29
10.99 12.5 14
11.58 13.15 14.72
DJO Sum
FY Est.
12/31/07E
Revenue Growth Rate
Revenue 873,572
26.50% EBITDA 253,833
-Interest Expense -176,485
16.39% -Change WC -15,700
8.28% -Taxes 10,969
8.28% -Capex -21,286
FCF 51,331
NOL

EBITDA/Interest Expense 1.44


EBITDA Margin 29.06%
EBITDA-Capex/Int Exp 1.32

Leverage Test
Consolidated Secured Debt Ratio
Senior Debt
EBITDA Requirement
EBITDA
Covenant Violation

Se

-4%
a 15% 0.62
M
20% 0.90
a 22% 1.00
r 24% 1.11
g
i
n 26.50% 1.25
s 28% 1.33
DJO Summary Financials and Projections
FY Est.
12/31/08E 12/31/09E 12/31/10E 12/31/11E
8.28% 8.28% 8.28%
980,194 1,061,354 1,149,234 1,244,391
259,600 281,259 304,547 329,764
-173,067 -173,067 -173,067 -173,067
-17,472 -13,300 -14,401 -15,594
-10,728 -11,616 -12,578 -13,620
-34,613 -37,479 -40,583 -43,943
23,720 45,797 63,919 83,541

1.50 1.63 1.76 1.91


26.48% 26.50% 26.50% 26.50%
1.30 1.41 1.53 1.65

4.25 3.5
1055 1055
248,235 301,429
281,259 304,547
No No

Sensitivity Analysis: EBITDA-Capex/Interest Expense (2009)


Revenue Growth
-2% 0% 2% 4%
0.64 0.65 0.66 0.68
0.91 0.93 0.95 0.97
1.03 1.05 1.07 1.09
1.14 1.16 1.18 1.21

1.27 1.30 1.33 1.35


1.36 1.39 1.41 1.44
12/31/12E
8.28%
1,347,426
357,068
-173,067
-16,885
-14,747
-47,581
104,788

2.06
26.50%
1.79

nse (2009)

6% 8% 10%
0.69 0.70 0.71
0.99 1.01 1.03
1.11 1.13 1.15
1.23 1.25 1.28

1.38 1.40 1.43


1.47 1.50 1.52
Year Ended December 31, 2008
Net sales
Cost of sales 374,080
Gross profit 606,114
Operating expenses:
Selling, general and administrative 445,396
Research and development 26,938
Amortization and impairment of
acquired intangibles 98,954
EBIT (loss) 34,826
Taxes
EBIT(1-t)
+ Depreciation
- Capital Expenditures
- Chg WC

FCFF

Other income (expense):


Interest income 1,662
Interest expense ($173,162.00)
Other income (expense), net ($9,134.00)
Loss on early extinguishment of debt -
Loss from continuing
operations before income
taxes and minority interests ($145,808.00)
Benefit for income taxes ($49,071.00)
Minority interests 1,049
Loss from continuing operations ($97,786.00)
Discontinued operations:
Net loss
ember 31, 2008
$980,194.00

($97,786.00)
Q2 2009 Q3 2009
Sales Sales Increase
Hip 5%
US 16%
Knee 3%
US 8%
Dental -16%
US -10%
Other 6%
US 26%
Total Reconstructive Products 449.31 453.8 1%
US 0 13%
Fixation 57 57 0%
US 0 1%
Spine 50.28 53.8 7%
US 0 15%
Other Products (Including Braces) 47.55 50.4 6%
US 0 14%
Total net Sales 604.81 $615 2%
US 352.64 $387.90 10%
Europe 192.87 167.8 -13%
Other Int'l 59.3 59.3 0%

604.81

You might also like